The Report Guru

Contrast media, also known as contrast agents or contrast dyes, are substances used in medical imaging to enhance the visibility of internal structures or organs. They work by altering the way X-rays, magnetic fields, or ultrasound waves interact with the tissues in the body. Contrast media are commonly used in diagnostic imaging procedures such as X-rays, CT scans, MRI scans, and ultrasounds. In this blog, we will discuss the contrast media market, its trends, and the factors driving its growth. Market Overview: The global contrast media market was valued at $5.1 billion in 2022 and is expected to grow at a CAGR of 3.7% from 2022 to 2027 and projected to reach $6.1 billion by 2027. The increasing prevalence of chronic diseases, growing demand for minimally invasive diagnostic procedures, and technological advancements in imaging modalities are some of the key factors driving the growth of the contrast media market. The market is segmented into two main categories: iodin...

Latest Trends in Contrast Media 1. Dual-Energy CT: Dual-energy CT is an imaging technique that uses two X-ray tubes to capture two images at different energies, allowing for better detection of contrast media. 2. Ultrasound Contrast Agents: Ultrasound contrast agents are microbubbles that are injected into the bloodstream and then detected by ultrasound. The microbubbles enhance the contrast of the images, allowing for better detection of abnormalities. 3. Magnetic Resonance Imaging (MRI) Contrast Agents: MRI contrast agents are small molecules that are injected into the bloodstream and detected by the MRI machine. These contrast agents enhance the contrast of the images, allowing for better detection of abnormalities. 4. Molecular Imaging: Molecular imaging is a new imaging technology that uses contrast agents that are targeted to specific molecules, such as proteins, to detect abnormalities. 5. Nanoparticle Contrast Agents: Nanoparticle contrast agents are tiny parti...

The growth in the Contrast Media Market can be attributed to the rising prevalence of chronic diseases, growing approvals of contrast agents, rising volume of CT and MRI examinations performed, growing number of diagnostic centers and hospitals, and availability of reimbursement. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, the high cost and inaccessibility of advanced therapeutics may restrict market growth to a certain extent. The contrast agents market is segmented based on type, modality, route of administration, indication, application, end user, and region. According to the market research report the global contrast media market size is projected to USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 Based on type, the contrast agents market is segmented in...

What is contrast media? Contrast media is a type of medical imaging contrast agent used to enhance the visibility of internal body structures during medical imaging procedures. Contrast agents are typically injected into the patient intravenously before the imaging procedure. Common types of medical imaging procedures that use contrast media include computed tomography (CT), magnetic resonance imaging (MRI), and angiography. There are two main types of contrast media: ionic and non-ionic. Ionic contrast media contains iodine, which is absorbed by the body and can cause side effects such as nausea, vomiting, and diarrhea. Non-ionic contrast media does not contain iodine and is less likely to cause side effects. Why the contrast media market is a good investment opportunity? The global contrast media market is growing rapidly, due to the increasing use of diagnostic imaging procedures. The major players in this market are GE Healthcare, Bayer AG, and Bracco S.p.A. This arti...

The growth in the contrast media market can be attributed to the rising prevalence of chronic diseases, growing approvals of contrast agents, rising volume of CT and MRI examinations performed, growing number of diagnostic centers and hospitals, and availability of reimbursement. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, high cost and inaccessibility of advanced therapeutics may restrict market growth to a certain extent. According to research report the global contrast media market size is projected to reach USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period. Based on type, the contrast agents market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barum-based contrast media. Iodinated contrast media account for the largest share of the contrast agents market. The large share of t...

The growth in this market can be attributed to the rising prevalence of chronic diseases, growing approvals of contrast agents, rising volume of CT and MRI examinations performed, growing number of diagnostic centers and hospitals, and availability of reimbursement. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, the high cost and inaccessibility of advanced therapeutics may restrict market growth to a certain extent. The contrast media market is segmented based on type, modality, route of administration, indication, application, end user, and region. According to the new market research report Contrast Media Market is projected to USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period. Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barum-based contras...

According to the new market research report “ Contrast Media Market by Type (Iodinated Contrast Media), Modality (X-Ray/CT, MRI, and Ultrasound), Application (Radiology), End User (Hospitals), Indication (Cancer), Route of Administration (Oral), Region - Global Forecast to 2026”, published by MarketsandMarkets™, the global Contrast Media Market is projected to USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 The Rising prevalence of chronic diseases, growing approvals of contrast agents, rising volume of CT and MRI examinations performed, growing number of diagnostic centers and hospitals, and availability of reimbursement are the major factors driving the growth of the contrast agents market. The microbubble contrast media segment is expected to grow at the highest CAGR during the forecast period and iodinated contrast media accounted for ...

 According to research report the Contrast Media Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 Growth in the market can primarily be attributed to the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe, increasing number of approvals of contrast agents. Rising research activities on contrast agents & their applications are the key areas of opportunity in this market GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India...

 According to research report the Contrast Media Contrast Agent Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 Growth in the market can primarily be attributed to the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe, increasing number of approvals of contrast agents. Rising research activities on contrast agents & their applications are the key areas of opportunity in this market GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B. Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea)...

 According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 Growth in the contrast agent market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations. However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent. North America to dominate the market in 2019 North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global contrast agent market study. North America is expected to account for the largest share of the global contrast media industry. The large...

  Growth in the contrast agent market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations. However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent. According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 North America to dominate the market in 2019 North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global contrast agent market study. North America is expected to account for the largest share of the global contrast media industry. The larg...

According to research report the global contrast media market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Growth in the contrast media market can primarily be attributed to factors such as the increasing prevalence of cancer & CVD, regulatory approval of a growing number of contrast agents, and the rising volume of CT & MRI examinations. However, the side effects and allergic reactions associated with contrast agents are expected to limit market growth to a certain extent. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 The major players in the global contrast media market are GE Healthcare (US), Bayer (Germany), Bracco Imaging S.p.A (Italy). An analysis of the market developments between 2016 and 2019 revealed that product launches, partnerships, expansions, and strategic acquisitions were adopted by market players to strengthe...

According to research report the global  contrast media market  is expected to reach USD 5.53 billion by 2022 from an estimated USD 4.57 billion in 2017, growing at a CAGR of 3.9% during the forecast period. The key factors driving the growth of this market are increasing approvals for contrast agents and growing number of public & private diagnostic centers. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911 On the basis of type, the contrast media market is categorized into barium-based, iodinated contrast media, gadolinium-based, and microbubble-based contrast media. The microbubble-based contrast media segment is expected to grow at the highest CAGR during the forecast period. Growth in the microbubble segment can be attributed to the large number of ongoing academic research activities exploring various attributes of microbubbles in off-label indications in diagnosis as well drug delivery. In addition, the rising number of approv...